Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 ...

Investing.com -- Novavax (NASDAQ: NASDAQ:NVAX) stock plummeted 24% after comments from Health and Human Services Secretary Robert F. Kennedy Jr. suggested a shift in government priorities away ...

Novavax experienced a noteworthy 13% increase in its share price last week, coinciding with significant changes in its leadership. The retirement of James Young as Chair of the Board and the ...

NEW YORK — President Donald Trump has launched tariff wars with nearly all of America’s trading partners. And there’s no end in sight. A number of sweeping new taxes on goods from other ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. CORNELIUS, Ore. (AP) — A woman and her three ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...

Novavax has faced significant regulatory setbacks in recent months that make its prospects uncertain. President Trump's trade policies are sending many stocks that were performing well in the ...

Full Food and Drug Administration approval would allow the vaccine to be used more widely and could offer more reassurance to people looking for options besides the existing mRNA vaccines.